Biohit has settled the dispute concerning a breach of the patent license agreement and therefore specifies its financial guidance for 2021
Biohit Oyj Stock Exchange Release February 8, 2022 at 12:00 local time (EET) Biohit Oyj’s (“Biohit”) shareholder Biohit HealthCare (Hefei) Co. Ltd (”Hefei”) acts as the exclusive distributor of Biohit’s certain GastroPanel products in China. Earlier, there has been a dispute between the companies regarding the application of the patent license agreement pertaining to the distribution cooperation. In order to resolve the dispute and some other controversies and claims related to the agreement between the parties, Biohit has submitted an application for the initiation of arbitration